History of hypersensitivity to salicylates (including mesalazine) or any of the excipients of Mezavant XL.
Severe renal impairment (GFR <30 mL/min/1.73 m2) and/or severe hepatic impairment.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.